SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28 | -50.9% | 11,835 | 0.0% | 0.00% | – |
| Q2 2023 | $57 | +3.6% | 11,835 | +21.2% | 0.00% | – |
| Q1 2023 | $55 | -12.7% | 9,768 | -13.1% | 0.00% | -100.0% |
| Q4 2022 | $63 | -99.9% | 11,244 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $72,000 | +89.5% | 11,244 | +1.6% | 0.00% | – |
| Q2 2022 | $38,000 | -53.1% | 11,065 | -2.4% | 0.00% | -100.0% |
| Q1 2022 | $81,000 | -60.3% | 11,332 | -53.9% | 0.00% | 0.0% |
| Q4 2021 | $204,000 | +131.8% | 24,576 | +94.6% | 0.00% | 0.0% |
| Q3 2021 | $88,000 | -71.9% | 12,626 | -3.9% | 0.00% | -66.7% |
| Q2 2021 | $313,000 | +48.3% | 13,143 | +52.5% | 0.00% | -62.5% |
| Q4 2020 | $211,000 | -9.8% | 8,621 | +4.4% | 0.01% | -20.0% |
| Q3 2020 | $234,000 | – | 8,254 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |